Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
基本信息
- 批准号:8411973
- 负责人:
- 金额:$ 35.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-15 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmyloid beta-ProteinBrainCharacteristicsComplexCultured CellsDataDementiaDiabetes MellitusDiseaseFamilyFemaleFunctional disorderGenderGene TransferGenerationsGeneticGenetic PolymorphismHumanInsulinInsulin ResistanceLinkMediatingMetabolicMetabolismModelingMolecularMusMutationNon-Insulin-Dependent Diabetes MellitusPatientsPeptidesPhenotypePhosphorylationProtein PrecursorsProteinsRiskRoleSerineStructureTertiary Protein StructureTestingTransgenic MiceVacuolar Protein SortingVertebral columnViral GenesWorkgenetic associationgenetic linkageglucose metabolismglucose tolerancehippocampal morphometryhypercholesterolemiainsulin tolerancelearned behavioroverexpressionprotein complexprotein metabolismprotein transportsexual dimorphismsortilintrafficking
项目摘要
SUMMARY
Type 2 diabetes mellitus (T2D or T2DM) increases the risk for Alzheimer's disease (AD), and SORCS1 is
genetically linked to both T2D and AD. We have undertaken a study of the possible role(s) for SorCS1 in
metabolism of the Alzheimer's amyloid-¿ (¿¿) precursor protein (APP), in order to define the molecular
mechanisms underlying this coordinate genetic linkage to both diseases. Overexpression of SorCS1c¿-myc
in cultured cells caused a reduction (p=0.002) in ¿¿ generation (Lane et al., 2010). Endogenous murine
A¿40 and ¿¿42 levels were increased (A¿40, p=0.044; A¿42, p=0.007) in the brains of female Sorcs1
hypomorphic mice, possibly paralleling the sexual dimorphism that is characteristic of the genetic
associations of SORCS1 with AD and DM. Since SorL1, another AD-linked Vps10-domain protein, directly
interacts with Vps35 to modulate APP metabolism, we investigated the possibility that SorCS1c¿-myc might
interact with APP, SorL1, and/or Vps35. We readily recovered SorCS1:APP, SorCS1:SorL1, and
SorCS1:Vps35 complexes from nontransgenic mouse brain. Notably, total Vps35 protein levels were
decreased by 49% (p=0.009) and total SorL1 protein levels were decreased by 29% (p=0.003) in the brains
of female Sorcs1-/- mice. We hypothesize that dysfunction of SorCS1 may contribute to both the APP/¿¿
disturbance underlying AD and the insulin/glucose metabolism disturbance underlying DM. In order to test
this hypothesis further, we propose the following specific aims: Specific Aim 1. To evaluate the importance
of SorCS1 protein interaction motifs and SorCS1/SorL1/APP complex formation on APP metabolism by: (a)
Characterizing APP metabolism in cultured cells overexpressing SorCS1; (b) Testing the effects of
mutations of protein-protein interacting motifs in the cytoplasmic and ectodomains of SorCS1 on both the
formation of tripartite SorCS1/SorL1/APP complexes and APP metabolism; (c) Testing the effect of a
putative pathogenic SorCS1 polymorphism on both the formation of tripartite SorCS1/SorL1/APP complexes
and APP metabolism; (d) Confirming the importance of functional domains identified in Aim 1aii and 1aiii by
viral gene transfer into primary cultures. Specific Aim 2. To employ Sorcs1 hypomorphic and plaque-
forming human Swedish APP/PS bigenic mice crossed with Sorcs1 hypomorphic mice for characterization
of: (i) endogenous APP metabolism; (ii) hippocampal morphometry, dendritic arborization, and spine
structure; (c) learning behavior. Aging (3 mo, 6 mo, 12 mo) effects will also be studied. Specific Aim 3. To
perform standard glucose and insulin tolerance tests and metabolic profile phenotyping of Sorcs1-/- mice
and plaque-forming" human Swedish APP/PS co-transgenic mice crossed with Sorcs1 -/- mice.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAMUEL E. GANDY其他文献
SAMUEL E. GANDY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAMUEL E. GANDY', 18)}}的其他基金
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
针对淀粉样蛋白或 Tau 神经变性的促神经源性治疗
- 批准号:
10378457 - 财政年份:2017
- 资助金额:
$ 35.78万 - 项目类别:
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
针对淀粉样蛋白或 Tau 神经变性的促神经源性治疗
- 批准号:
9911993 - 财政年份:2017
- 资助金额:
$ 35.78万 - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
9220567 - 财政年份:2014
- 资助金额:
$ 35.78万 - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
8596270 - 财政年份:2014
- 资助金额:
$ 35.78万 - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
9026594 - 财政年份:2014
- 资助金额:
$ 35.78万 - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
8825927 - 财政年份:2014
- 资助金额:
$ 35.78万 - 项目类别:
Generation and Characterization of Alzheimer Brain Cells
阿尔茨海默病脑细胞的生成和表征
- 批准号:
8370239 - 财政年份:2012
- 资助金额:
$ 35.78万 - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8599496 - 财政年份:2012
- 资助金额:
$ 35.78万 - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8788636 - 财政年份:2012
- 资助金额:
$ 35.78万 - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8295466 - 财政年份:2012
- 资助金额:
$ 35.78万 - 项目类别:














{{item.name}}会员




